295 Capecitabine plus irinotecan (CAPIRI) vs capecitabine plus oxaliplatin (CAPOX) as first-line therapy of advanced colorectal cancer (ACRC): updated results of a randomized phase II trial
作者: A. Grothey , K. Jordan , O. Kellner , C. Constantin , G. Dietrich
DOI: 10.1016/S1359-6349(03)90328-4
关键词: